This pharmaceutical company is a major player in the global market, with established production bases across multiple regions. They boast a wide range of products, including prescription medications and over-the-counter drugs, catering to diverse therapeutic areas such as respiratory health, pain management, gastrointestinal disorders, and infectious diseases. Their product portfolio encompasses various dosage forms like oral solids, injections, topical creams, and infusions, manufactured under strict GMP certifications. The company holds several patents for their innovative drug formulations, solidifying its competitive advantage in the industry.
Manufacturer usually replies in nan days
Tenoxicam:
Tenoxicam, also known under the popular brand name Mobiflex, is a nonsteroidal anti-inflammatory medication used in the treatment of indications such as inflammation, swelling, stiffness, rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, tendinitis, bursitis, and periarthritis of the shoulders or hips. It was originally patented by the pharmaceutical products manufacturing company Roche in 1974, following approval for medical sale on the marketplace in 1987.
Currently, it can be found for global sale and wholesale by many tenoxicam manufacturers and tenoxicam suppliers under other brand names including Tilatil, Tilcitin, and Alganex, along with other generic variations. This emerged genericness, driven by the expiration of the pharmaceutical products patent, has in large part accelerated its popularity. Making it both cost-effective and attractive for distributors to list for sale on the global marketplace. Where it can be found under numerous names and at various price points.
Method of action of tenoxicam:
Tenoxicam belongs to a group of medications termed nonsteroidal anti-inflammatory drugs, specifically it is within the oxicams class. This class binds closely to plasma proteins to carry out its effects. Although the exact mechanism of action for tenoxicam remains obscure, it is thought that it functions through the inhibition of cyclooxygenase by deactivation or irregulation of its underlying genes of COX-1 and COX-2. This subsequently causes peripheral inhibition of prostaglandin synthesis, which is necessary to sensitize pain receptors. Therefore, their inhibition accounts for the analgesic effects of tenoxicam. Additionally, antipyresis may occur through central action on the hypothalamus, resulting in peripheral dilation, increased blood flow, and heat loss.
Form and dosage of tenoxicam:
As with other drugs, the final form and packaging of tenoxicam is dependent on the manufacturers and suppliers, as well as the distributors and specific order. However, tenoxicam is typically listed for sale in different forms such as tablets, film-coated-tablets, solution for injection, and capsules. Tenoxicam is a prescription medication in most countries, such as the United Kingdom, but remains over the counter in others, such as the United States. Therefore, it is recommended that the local regulations be checked before attempting to acquire this product. Normal doses for the treatment of pain and inflammation in rheumatic disease and acute musculoskeletal disorders tend to be 20 mg once daily by mouth, or 20 mg once daily for 1–2 days through the intravenous injection or by intramuscular injection route. These values are however subject to change based on the manufacturers’ literature and professional medical advice.
Tenoxicam on Pipelinepharma:
Currently, we have found 9 trusted tenoxicam manufacturers and tenoxicam suppliers from our global list of online B2B wholesale sellers. These manufacturers and wholesale providers are located in various countries including the European Union, Egypt, Guatemala, and Bangladesh. Each company listed on our online B2B marketplace has been verified by the Pipelinepharma team according to strict quality control. This ensures the seriousness of each provider while reducing sourcing mileage, making for a hassle-free experience for all parties.
Price of tenoxicam and how to buy:
The cost of tenoxicam is highly dependent on numerous variables such as organisation, quantity, and market. Therefore, the price is subject to change, and an exact figure cannot be given. However, to aid in the sourcing process, manufacturers, suppliers, and distributors may choose to list their desired cost for their product on the online Pipelinepharma B2B marketplace. If indicated, an ‘Accept’ and ‘Negotiate’ button will appear next to the listing. In the absence of an indicated price, a ‘Get offer’ button will be displayed instead. This interface encourages a rapid transaction period, cutting down on overhead costs while increasing satisfaction for all parties.
